BG106026A - 1-АМИНОТРИАЗОЛО/4,3-а/ХИНАЗОЛИН-5-ОНИ И/ИЛИ -5-ТИОНИ ИНХИБИРАЩИ ФОСФОДИЕСТЕРАЗА IV - Google Patents
1-АМИНОТРИАЗОЛО/4,3-а/ХИНАЗОЛИН-5-ОНИ И/ИЛИ -5-ТИОНИ ИНХИБИРАЩИ ФОСФОДИЕСТЕРАЗА IV Download PDFInfo
- Publication number
- BG106026A BG106026A BG106026A BG10602601A BG106026A BG 106026 A BG106026 A BG 106026A BG 106026 A BG106026 A BG 106026A BG 10602601 A BG10602601 A BG 10602601A BG 106026 A BG106026 A BG 106026A
- Authority
- BG
- Bulgaria
- Prior art keywords
- triazolo
- quinazolin
- bromo
- pyrrolidin
- azepan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9905398A FR2792938B1 (fr) | 1999-04-28 | 1999-04-28 | NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV |
PCT/FR2000/001174 WO2000066584A1 (fr) | 1999-04-28 | 2000-04-28 | 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES ET/OU -5-THIONES INHIBITRICES DE PHOSPHODIESTERASES IV |
Publications (1)
Publication Number | Publication Date |
---|---|
BG106026A true BG106026A (bg) | 2002-05-31 |
Family
ID=9544983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG106026A BG106026A (bg) | 1999-04-28 | 2001-10-18 | 1-АМИНОТРИАЗОЛО/4,3-а/ХИНАЗОЛИН-5-ОНИ И/ИЛИ -5-ТИОНИ ИНХИБИРАЩИ ФОСФОДИЕСТЕРАЗА IV |
Country Status (34)
Country | Link |
---|---|
US (1) | US6828315B1 (da) |
EP (1) | EP1177195B1 (da) |
JP (1) | JP2002543199A (da) |
KR (1) | KR20020008166A (da) |
CN (1) | CN1352644A (da) |
AP (1) | AP2001002309A0 (da) |
AT (1) | ATE234840T1 (da) |
AU (1) | AU4411500A (da) |
BG (1) | BG106026A (da) |
BR (1) | BR0010072A (da) |
CA (1) | CA2388658A1 (da) |
DE (1) | DE60001735T2 (da) |
DK (1) | DK1177195T3 (da) |
DZ (1) | DZ3154A1 (da) |
EA (1) | EA004373B1 (da) |
EE (1) | EE200100566A (da) |
ES (1) | ES2194779T3 (da) |
FR (1) | FR2792938B1 (da) |
HK (1) | HK1044938B (da) |
HR (1) | HRP20010794B1 (da) |
HU (1) | HUP0202656A3 (da) |
IL (1) | IL146178A0 (da) |
IS (1) | IS6114A (da) |
MA (1) | MA27343A1 (da) |
MX (1) | MXPA01010888A (da) |
NO (1) | NO20015235L (da) |
OA (1) | OA11875A (da) |
PL (1) | PL351951A1 (da) |
PT (1) | PT1177195E (da) |
SK (1) | SK15322001A3 (da) |
TR (1) | TR200103099T2 (da) |
WO (1) | WO2000066584A1 (da) |
YU (1) | YU76401A (da) |
ZA (1) | ZA200108847B (da) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1188438A1 (en) * | 2000-09-15 | 2002-03-20 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
EP1199074A1 (en) * | 2000-09-15 | 2002-04-24 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
PA8539501A1 (es) * | 2001-02-14 | 2002-09-30 | Warner Lambert Co | Compuestos triazolo como inhibidores de mmp |
CA2447619A1 (en) * | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | A composition for accelerating bone fracture healing |
EP1285922A1 (en) * | 2001-08-13 | 2003-02-26 | Warner-Lambert Company | 1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
FR2832711B1 (fr) * | 2001-11-26 | 2004-01-30 | Warner Lambert Co | Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation |
DE10229778A1 (de) * | 2002-07-03 | 2004-01-29 | Bayer Ag | Neue Verwendung von Imidazotriazinonen |
CA2504820C (en) * | 2002-11-06 | 2011-08-23 | Grelan Pharmaceutical Co., Ltd. | Pyrazolonaphthyridine derivatives |
NZ541232A (en) | 2003-01-09 | 2008-02-29 | Astellas Pharma Inc | Pyrrolopyridazine derivatives |
ZA200609228B (en) * | 2004-04-23 | 2008-05-28 | Celgene Corp | Methods of using and compositions comprising PDE4 modulators for the treatment and management of pulmonary hypertension |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
WO2007025177A2 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2377530A3 (en) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
MX2009002496A (es) | 2006-09-08 | 2009-07-10 | Braincells Inc | Combinaciones que contienen un derivado de 4-acilaminopiridina. |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
KR101129868B1 (ko) | 2006-10-04 | 2012-04-12 | 화이자 프로덕츠 인코포레이티드 | 칼슘 수용체 길항제로서의 피리도[4,3-d]피리미딘-4(3H)-온 유도체 |
WO2009013286A1 (en) * | 2007-07-24 | 2009-01-29 | Novartis Ag | Organic compounds |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
CN103224498B (zh) * | 2013-05-07 | 2015-10-28 | 陈定奔 | 两种唑并喹唑啉酮稠杂环的新合成方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3865824A (en) * | 1972-03-07 | 1975-02-11 | Icn Pharmaceuticals | 2-Aryl-7-substituted pyrazolo {8 1,5{i a{b {9 1,3,5-triazines |
US3850932A (en) * | 1973-06-28 | 1974-11-26 | Sandoz Ag | 5-(2-carboxy and 2-carboalkoxy-phenylamino)-1,2,4-triazolo-quinazolines |
IL66835A (en) * | 1981-09-24 | 1988-05-31 | Roussel Uclaf | 1,4-disubstituted(1,2,4)triazolo(4,3-alpha)quinazolin-5(4h)-one derivatives and their salts,their preparation and pharmaceutical compositions containing them |
JPS6028979A (ja) * | 1983-07-14 | 1985-02-14 | Dai Ichi Seiyaku Co Ltd | イミダゾキナゾリン類化合物 |
SK282167B6 (sk) * | 1995-06-06 | 2001-11-06 | Pfizer Inc. | Tricyklické 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a] pyridíny a farmaceutický prostriedok na ich báze |
ES2137113B1 (es) * | 1997-07-29 | 2000-09-16 | Almirall Prodesfarma Sa | Nuevos derivados de triazolo-piridazinas heterociclicos. |
-
1999
- 1999-04-28 FR FR9905398A patent/FR2792938B1/fr not_active Expired - Lifetime
-
2000
- 2000-04-28 WO PCT/FR2000/001174 patent/WO2000066584A1/fr active Search and Examination
- 2000-04-28 PT PT00967407T patent/PT1177195E/pt unknown
- 2000-04-28 HU HU0202656A patent/HUP0202656A3/hu unknown
- 2000-04-28 KR KR1020017013825A patent/KR20020008166A/ko not_active Application Discontinuation
- 2000-04-28 BR BR0010072-2A patent/BR0010072A/pt not_active IP Right Cessation
- 2000-04-28 DZ DZ003154A patent/DZ3154A1/xx active
- 2000-04-28 DK DK00967407T patent/DK1177195T3/da active
- 2000-04-28 CA CA002388658A patent/CA2388658A1/en not_active Abandoned
- 2000-04-28 EA EA200100994A patent/EA004373B1/ru not_active IP Right Cessation
- 2000-04-28 ES ES00967407T patent/ES2194779T3/es not_active Expired - Lifetime
- 2000-04-28 DE DE60001735T patent/DE60001735T2/de not_active Expired - Fee Related
- 2000-04-28 EP EP00967407A patent/EP1177195B1/fr not_active Expired - Lifetime
- 2000-04-28 CN CN00808153A patent/CN1352644A/zh active Pending
- 2000-04-28 SK SK1532-2001A patent/SK15322001A3/sk unknown
- 2000-04-28 IL IL14617800A patent/IL146178A0/xx unknown
- 2000-04-28 AT AT00967407T patent/ATE234840T1/de not_active IP Right Cessation
- 2000-04-28 OA OA1200100282A patent/OA11875A/fr unknown
- 2000-04-28 TR TR2001/03099T patent/TR200103099T2/xx unknown
- 2000-04-28 PL PL00351951A patent/PL351951A1/xx not_active Application Discontinuation
- 2000-04-28 MX MXPA01010888A patent/MXPA01010888A/es active IP Right Grant
- 2000-04-28 YU YU76401A patent/YU76401A/sh unknown
- 2000-04-28 JP JP2000615614A patent/JP2002543199A/ja active Pending
- 2000-04-28 EE EEP200100566A patent/EE200100566A/xx unknown
- 2000-04-28 US US09/980,540 patent/US6828315B1/en not_active Expired - Fee Related
- 2000-04-28 AP APAP/P/2001/002309A patent/AP2001002309A0/en unknown
- 2000-04-28 AU AU44115/00A patent/AU4411500A/en not_active Abandoned
-
2001
- 2001-10-18 BG BG106026A patent/BG106026A/bg unknown
- 2001-10-19 IS IS6114A patent/IS6114A/is unknown
- 2001-10-23 MA MA26381A patent/MA27343A1/fr unknown
- 2001-10-26 ZA ZA200108847A patent/ZA200108847B/xx unknown
- 2001-10-26 HR HR20010794A patent/HRP20010794B1/xx not_active IP Right Cessation
- 2001-10-26 NO NO20015235A patent/NO20015235L/no not_active Application Discontinuation
-
2002
- 2002-08-05 HK HK02105712.4A patent/HK1044938B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG106026A (bg) | 1-АМИНОТРИАЗОЛО/4,3-а/ХИНАЗОЛИН-5-ОНИ И/ИЛИ -5-ТИОНИ ИНХИБИРАЩИ ФОСФОДИЕСТЕРАЗА IV | |
US6747035B2 (en) | 1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors | |
AU744014B2 (en) | 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof | |
EP2362876B1 (en) | Thienotriazolodiazepine derivatives active on apo a | |
CA2468673C (en) | Compounds specific to adenosine a1 and a3 receptors and uses thereof | |
EP0804440B1 (en) | Tricyclic benzazepine vasopressin antagonists | |
WO2009077956A2 (ru) | ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Нh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ | |
JP2005531584A (ja) | ピラゾロピリミジンアニリン化合物 | |
BG107750A (bg) | ПИРОЛОТРИАЗИНОВИ СЪЕДИНЕНИЯ И ИЗПОЛЗВАНЕТО ИМ КАТО ИНХИБИТОРИ НА р38 КИНАЗА | |
PT1246623E (pt) | Compostos específicos para o receptor de adenosina a1,a2a e a3 e as suas utilizações | |
WO2000073306A1 (fr) | Derives de 2-arylpurine-9-acetamide, leur procede de preparation, compositions medicinales les contenant et intermediaires des derives | |
TW201300390A (zh) | 喹□啉化合物 | |
KR20190028544A (ko) | 인간 pde1 억제제로서 유용한 트리아졸로피라지논 유도체 | |
KR20060030908A (ko) | N-[3-(3-치환된-피라졸로[1,5-a]피리미딘-7-일)페닐]-술폰아미드, 및 조성물과 그 관련된 방법 | |
EP1248787B1 (en) | NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM | |
JP2002536449A (ja) | Gabaレセプターに対するリガンドとしてのトリアゾロ−ピリダジン誘導体 | |
US20070043064A1 (en) | 7-Substituted 3-nitro-pyrazo[1,5-a] pyrimidines | |
US6962912B2 (en) | Substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them | |
WO2024067694A1 (zh) | 含氮杂环类化合物及其医药用途 |